Digital Subtraction Angiography Prior to an Amputation for Critical Limb Ischemia (CLI): An Expert Recommendation Statement From the CLI Global Society to Optimize Limb Salvage
Restricted accessResearch articleFirst published online August, 2020
Digital Subtraction Angiography Prior to an Amputation for Critical Limb Ischemia (CLI): An Expert Recommendation Statement From the CLI Global Society to Optimize Limb Salvage
Despite recent guideline updates on peripheral artery disease (PAD) and critical limb ischemia (CLI) treatment, the optimal treatment for CLI is still being debated. As a result, care is inconsistent, with many CLI patients undergoing an amputation prior to what many consider to be mandatory: consultation with an interdisciplinary specialty care team and a comprehensive imaging assessment. More importantly, quality imaging is critical in CLI patients with below-the-knee disease. Therefore, the CLI Global Society has put forth an interdisciplinary expert recommendation for superselective digital subtraction angiography (DSA) that includes the ankle and foot in properly indicated CLI patients to optimize limb salvage. A recommended imaging algorithm for CLI patients is included.
FowkesFGRRudanDRudanI, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329–1340.
2.
HirschATDuvalS.The global pandemic of peripheral artery disease. Lancet. 2013;382:1312–1314.
3.
ConteMSBradburyAWKolhP, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69:3S–125S.e40.
4.
PatelMRConteMSCutlipDE, et al. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC). J Am Coll Cardiol. 2015;65:931–941.
5.
ShishehborMHWhiteCJGrayBH, et al. Critical limb ischemia: an expert statement. J Am Coll Cardiol. 2016;68:2002–2015.
6.
OlinJWWhiteCJArmstrongEJ, et al. Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options. J Am Coll Cardiol. 2016;67:1338–1357.
7.
KinlayS.Management of critical limb ischemia. Circ Cardiovasc Interv. 2016;9:e001946.
8.
Gerhard-HermanMDGornikHLBarrettC, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2017;69:e71–e126.
9.
MustaphaJAKatzenBTNevilleRF, et al. Determinants of long-term outcomes and costs in the management of critical limb ischemia: a population-based cohort study. J Am Heart Assoc. 2018;7:e009724. doi:10.1161/JAHA.118.009724
10.
BiancariF.Meta-analysis of the prevalence, incidence and natural history of critical limb ischemia. J Cardiovasc Surg (Torino). 2013;54:663–669.
11.
NehlerMRDuvalSDiaoL, et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014;60:686–695.e2.
12.
EggersPWGohdesDPughJ.Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int. 1999;56:1524–1533.
13.
Abu DabrhAMSteffenMWUndavalliC, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015;62:1642–1651.e3.
14.
MustaphaJAKatzenBTNevilleRF, et al. Disease burden and clinical outcomes following initial diagnosis of critical limb ischemia in the Medicare population. JACC Cardiovasc Interv. 2018;11:1011–1012.
15.
ValleJAWaldoSW.Worth an arm and a leg: the critical importance of limb ischemia. J Am Heart Assoc. 2018;7:e010093. doi:10.1161/JAHA.118.010093
16.
JindeelANaraharaKA.Nontraumatic amputation: incidence and cost analysis. Int J Low Extrem Wounds. 2012;11:177–179.
17.
DillinghamTRPezzinLEShoreAD.Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations. Arch Phys Med Rehabil. 2005;86:480–486.
18.
PasquinaPFMillerMCarvalhoAJ, et al. Special considerations for multiple limb amputation. Curr Phys Med Rehabil Rep. 2014;2:273–289.
19.
SchofieldCJLibbyGBrennanGM, et al. Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes. Diabetes Care. 2006;29:2252–2256.
20.
TentolourisNAl-SabbaghSWalkerMG, et al. Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study. Diabetes Care. 2004;27:1598–1604.
21.
FagliaEClericiGClerissiJ, et al. Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg. 2006;32:484–490.
22.
LiYBurrowsNRGreggEW, et al. Declining rates of hospitalization for nontraumatic lower-extremity amputation in the diabetic population aged 40 years or older: U.S., 1988-2008. Diabetes Care. 2012;35:273–277.
23.
HenryAJHeveloneNDBelkinM, et al. Socioeconomic and hospital-related predictors of amputation for critical limb ischemia. J Vasc Surg. 2011;53:330–339.e1.
24.
GoodneyPPTravisLLNallamothuBK, et al. Variation in the use of lower extremity vascular procedures for critical limb ischemia. Circ Cardiovasc Qual Outcomes. 2012;5:94–102.
25.
ReineckeHUnrathMFreisingerE, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015;36:932–938.
26.
SukulDGreySFHenkePK, et al. Heterogeneity of ankle-brachial indices in patients undergoing revascularization for critical limb ischemia. JACC Cardiovasc Interv. 2017;10:2307–2316.
27.
BjörckMEarnshawJJAcostaS, et al. European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia. Eur J Vasc Endovasc Surg. 2020;59:173–218.
MustaphaJADiaz-SandovalLJSaabF.Innovations in the endovascular management of critical limb ischemia: retrograde tibiopedal access and advanced percutaneous techniques. Curr Cardiol Rep. 2017;19:68.
30.
PomposelliF.Arterial imaging in patients with lower extremity ischemia and diabetes mellitus. J Vasc Surg. 2010;52:81S–91S.
31.
HigashimoriA.Angiography and endovascular therapy for below-the-knee artery disease. In: YokoiYFukudaKFujiharaMetal., eds. Angiography and Endovascular Therapy for Below-the-Knee Artery Disease. IntechOpen; 2017. doi:10.5772/67179
32.
WeiL-MZhuY-QZhangP-L, et al. Evaluation of quiescent-interval single-shot magnetic resonance angiography in diabetic patients with critical limb ischemia undergoing digital subtraction angiography: comparison with contrast-enhanced magnetic resonance angiography with calf compression at 3.0 Tesla. J Endovasc Ther. 2019;26:44–53.
33.
Varga-SzemesAWichmannJLSchoepfUJ, et al. Accuracy of noncontrast quiescent-interval single-shot lower extremity MR angiography versus CT angiography for diagnosis of peripheral artery disease: comparison with digital subtraction angiography. JACC Cardiovasc Imaging. 2017;10:1116–1124.
34.
TroisiNTuriniFChisciE, et al. Impact of pedal arch patency on tissue loss and time to healing in diabetic patients with foot wounds undergoing infrainguinal endovascular revascularization. Korean J Radiol. 2018;19:47–53.
35.
CuryMVMMatieloMFBrochado NetoFC, et al. The incidence, risk factors, and outcomes of contrast-induced nephropathy in patients with critical limb ischemia following lower limb angiography. Angiology. 2018;69:700–708.
36.
PalenaLMDiaz-SandovalLJCandeoA, et al. Automated carbon dioxide angiography for the evaluation and endovascular treatment of diabetic patients with critical limb ischemia. J Endovasc Ther. 2016;23:40–48.
37.
ScaliseFNovelliEAuguadroC, et al. Automated carbon dioxide digital angiography for lower-limb arterial disease evaluation: safety assessment and comparison with standard iodinated contrast media angiography. J Invasive Cardiol. 2015;27:20–26.
